BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33290995)

  • 21. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
    Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
    Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
    Savino L; Borruto F; Comparetto C; Massi GB
    Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
    Metindir J; Bilir G
    Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node identification and radical hysterectomy with lymphadenectomy in early stage cervical cancer: laparoscopy versus laparotomy.
    Díaz-Feijoo B; Gil-Moreno A; Pérez-Benavente MA; Morchón S; Martínez-Palones JM; Xercavins J
    J Minim Invasive Gynecol; 2008; 15(5):531-7. PubMed ID: 18657483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
    Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer.
    Matsuo K; Shimada M; Yamaguchi S; Matoda M; Nakanishi T; Kikkawa F; Ohmichi M; Okamoto A; Sugiyama T; Mikami M
    Obstet Gynecol; 2019 Jun; 133(6):1086-1098. PubMed ID: 31135722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical hysterectomy for cervical cancer in obese women.
    Cohn DE; Swisher EM; Herzog TJ; Rader JS; Mutch DG
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):727-31. PubMed ID: 11042308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
    Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
    Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer.
    Dostalek L; Slama J; Fisherova D; Kocian R; Germanova A; Fruhauf F; Dusek L; Dundr P; Nemejcova K; Jarkovsky J; Cibula D
    Int J Gynecol Cancer; 2020 Jun; 30(6):744-748. PubMed ID: 32276933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.